Compare KYMR & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYMR | ACMR |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.8B |
| IPO Year | 2020 | 2017 |
| Metric | KYMR | ACMR |
|---|---|---|
| Price | $119.06 | $93.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 26 | 1 |
| Target Price | ★ $107.72 | $50.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | $39,211,000.00 | ★ $74,643,000.00 |
| Revenue This Year | $10.61 | $29.37 |
| Revenue Next Year | $8.17 | $23.16 |
| P/E Ratio | ★ N/A | $410.50 |
| Revenue Growth | N/A | ★ 104.47 |
| 52 Week Low | $36.88 | $23.03 |
| 52 Week High | $130.05 | $127.19 |
| Indicator | KYMR | ACMR |
|---|---|---|
| Relative Strength Index (RSI) | 76.01 | 48.54 |
| Support Level | $72.91 | $35.32 |
| Resistance Level | $130.05 | $94.21 |
| Average True Range (ATR) | 7.67 | 9.75 |
| MACD | 2.01 | -2.04 |
| Stochastic Oscillator | 76.15 | 9.86 |
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.